Pharmerica
Cash Flow

Last updated:

Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Pharmerica generated cash of $30,800,000, which is more than the previous year. Cash used in financing activities reached the amount of $43,200,000 last year. Net change in cash is therefore -$17,700,000.

Cash Flow

Pharmerica Corporation (NYSE:PMC): Cash Flow
2013 3M 24.2M -3M
2014 48.4M -157M 117.7M
2015 18.5M -104.1M 75.4M
2016 30.8M -91.7M 43.2M

PMC Cash Flow Statement (2013 – 2016)

2016 2015 2014 2013
Cash at beginning of period
23.1M33.3M24.2M52M
Operating activities
Net income
21.6M35.1M6.8M18.9M
Adjustments to reconcile net income to cash generated by operating activities:
Depreciation and amortization
58.1M52.3M42.3M4M
Stock-based compensation expense
0002M
Deferred income tax benefit 0002M
Changes in operating assets and liabilities:
Accounts receivable, net
-34.3M-2M29M1M
Inventories
-56.7M-15.9M-18.8M-32M
Accounts payable
36.4M-24M-2.9M13M
Cash generated by operating activities
30.8M18.5M48.4M3M
Investing activities
Purchases Of Investments
0000
Investments In Property Plant And Equipment
-34.2M-23.9M-25.6M0
Acquisitions Net
-57.6M-83.6M-133.7M-26.5M
Cash generated by investing activities
-91.7M-104.1M-157M24.2M
Financing activities
Common Stock Issued
200K800K3.4M0
Payments for dividends
0000
Repurchases of common stock
-5.4M-23.1M-33.3M-24.2M
Repayments of term debt
-11.3M0-231.3M-3M
Cash used in financing activities
43.2M75.4M117.7M-3M
Net Change In Cash
-17.7M-10.2M9.1M-27.8M
Cash at end of period
5.4M23.1M33.3M24.2M
Data sourceData sourceData sourceData source